Clinical perspectives on lupus genetics: Advances and opportunities

Rheumatic Disease Clinics of North America

Volumn 40, Issue 3, 2014, Pages 413-432

  James, Judith A ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoantibodies; Clinical subphenotypes; Genetics; GWAS; Lupus; Nephritis; SLE

Indexed keywords

AUTOANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; OX40 LIGAND; STAT4 PROTEIN; TOLL LIKE RECEPTOR;

A20 BINDING INHIBITOR OF NUCLEAR FACTOR KAPPA BETA GENE; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIPHOSPHOLIPID SYNDROME; APOLIPOPROTEIN L1 GENE; APOPTOSIS; ARTHRITIS; B LYMPHOCYTE; COMORBIDITY; DNA DEGRADATION; FC GAMMA RECEPTOR GENE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; HUMAN; INNATE IMMUNITY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PERICARDITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STAT4 GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THROMBOSIS; TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 4 GENE; UBIQUITINATION; COMPLICATION; GENETIC PREDISPOSITION; IMMUNITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PATHOPHYSIOLOGY;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; IMMUNITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; UBIQUITINATION;

EID: 84904381579     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2014.04.002     Document Type: Review

References (150)

1. Block S.R., Winfield J.B., Lockshin M.D., et al. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med 1975, 59(4):533-552.
2. Deapen D., Escalante A., Weinrib L., et al. Arevised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992, 35(3):311-318.
3. Guerra S.G., Vyse T.J., Cunninghame Graham D.S. The genetics of lupus: a functional perspective. Arthritis Res Ther 2012, 14(3):211.
4. Graham R.R., Cotsapas C., Davies L., et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008, 40(9):1059-1061.
5. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40(2):204-210.
6. Hom G., Graham R.R., Modrek B., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. NEngl J Med 2008, 358(9):900-909.
7. Tiffin N., Adeyemo A., Okpechi I. Adiverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus. Orphanet J Rare Dis 2013, 8:2.
8. Rullo O.J., Tsao B.P. Recent insights into the genetic basis of systemic lupus erythematosus. Ann Rheum Dis 2013, 72(Suppl 2):ii56-ii61.
9. Costa-Reis P., Sullivan K.E. Genetics and epigenetics of systemic lupus erythematosus. Curr Rheumatol Rep 2013, 15(9):369.
10. Deng Y., Tsao B.P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 2010, 6(12):683-692.
11. Kelley J.M., Edberg J.C., Kimberly R.P. Pathways: strategies for susceptibility genes in SLE. Autoimmun Rev 2010, 9(7):473-476.
12. Moser K.L., Kelly J.A., Lessard C.J., et al. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009, 10(5):373-379.
13. Flesher D.L., Sun X., Behrens T.W., et al. Recent advances in the genetics of systemic lupus erythematosus. Expert Rev Clin Immunol 2010, 6(3):461-479.
14. Musone S.L., Taylor K.E., Lu T.T., et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 2008, 40(9):1062-1064.
15. Kawasaki A., Ito S., Furukawa H., et al. Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study. Arthritis Res Ther 2010, 12(5):R174.
16. Caster D.J., Korte E.A., Nanda S.K., et al. ABIN1 dysfunction as a genetic basis for lupus nephritis. JAm Soc Nephrol 2013, 24(11):1743-1754.
17. Hepburn A.L., Mason J.C., Wang S., et al. Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions invitro. Clin Exp Immunol 2006, 146(1):133-145.
18. MacPherson M., Lek H.S., Prescott A., et al. Asystemic lupus erythematosus-associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis. JBiol Chem 2011, 286(19):17303-17310.
19. Nath S.K., Han S., Kim-Howard X., et al. Anonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 2008, 40(2):152-154.
20. Ronnblom L. The type I interferon system in the etiopathogenesis of autoimmune diseases. Ups J Med Sci 2011, 116(4):227-237.
21. Ramos P.S., Williams A.H., Ziegler J.T., et al. Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus. Arthritis Rheum 2011, 63(7):2049-2057.
22. Cunninghame Graham D.S., Morris D.L., Bhangale T.R., et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 2011, 7(10):e1002341.
23. Han J.W., Zheng H.F., Cui Y., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009, 41(11):1234-1237.
24. Stone J.C. Regulation of Ras in lymphocytes: get a GRP. Biochem Soc Trans 2006, 34(Pt 5):858-861.
25. Chang Y.K., Yang W., Zhao M., et al. Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun 2009, 10(5):414-420.
26. Cunninghame Graham D.S., Graham R.R., Manku H., et al. Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet 2008, 40(1):83-89.
27. Farres M.N., Al-Zifzaf D.S., Aly A.A., et al. OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis. Ann Saudi Med 2011, 31(1):29-34.
28. Gramaglia I., Jember A., Pippig S.D., et al. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. JImmunol 2000, 165(6):3043-3050.
29. Criswell L.A., Pfeiffer K.A., Lum R.F., et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005, 76(4):561-571.
30. Lea W.W., Lee Y.H. The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update. Lupus 2011, 20(1):51-57.
31. Remmers E.F., Plenge R.M., Lee A.T., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. NEngl J Med 2007, 357(10):977-986.
32. Lessard C.J., Adrianto I., Kelly J.A., et al. Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet 2011, 88(1):83-91.
33. Hu W., Sun L., Gao J., et al. Down-regulated expression of IKZF1 mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Rheumatol Int 2011, 31(6):819-822.
34. Sullivan K.E., Piliero L.M., Dharia T., et al. 3' Polymorphisms of ETS1 are associated with different clinical phenotypes in SLE. Hum Mutat 2000, 16(1):49-53.
35. Bories J.C., Willerford D.M., Grevin D., et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 1995, 377(6550):635-638.
36. Eyquem S., Chemin K., Fasseu M., et al. The development of early and mature B cells is impaired in mice deficient for the Ets-1 transcription factor. Eur J Immunol 2004, 34(11):3187-3196.
37. Wang D., John S.A., Clements J.L., et al. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int Immunol 2005, 17(9):1179-1191.
38. Wojcik H., Griffiths E., Staggs S., et al. Expression of a non-DNA-binding Ikaros isoform exclusively in B cells leads to autoimmunity but not leukemogenesis. Eur J Immunol 2007, 37(4):1022-1032.
39. Fernando M.M., Freudenberg J., Lee A., et al. Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis 2012, 71(5):777-784.
40. Fernando M.M., Stevens C.R., Sabeti P.C., et al. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 2007, 3(11):e192.
41. Graham R.R., Ortmann W., Rodine P., et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 2007, 15(8):823-830.
42. Ramos P.S., Kelly J.A., Gray-McGuire C., et al. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun 2006, 7(5):417-432.
43. Chung S.A., Taylor K.E., Graham R.R., et al. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet 2011, 7(3):e1001323.
44. Isenberg D.A., Manson J.J., Ehrenstein M.R., et al. Fifty years of anti-ds DNA antibodies: are we approaching journey's end?. Rheumatology (Oxford) 2007, 46(7):1052-1056.
45. Kessel A., Rosner I., Halasz K., et al. Antibody clustering helps refine lupus prognosis. Semin Arthritis Rheum 2009, 39(1):66-70.
46. Kawasaki A., Furukawa H., Kondo Y., et al. Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population. Lupus 2012, 21(8):890-895.
47. Namjou B., Kim-Howard X., Sun C., et al. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. PLoS One 2013, 8(8):e69404.
48. Chrabot B.S., Kariuki S.N., Zervou M.I., et al. Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Genes Immun 2013, 14(8):471-478.
49. Kariuki S.N., Franek B.S., Mikolaitis R.A., et al. Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients. JBiomed Biotechnol 2010, 2010:826434.
50. Salloum R., Franek B.S., Kariuki S.N., et al. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum 2010, 62(2):553-561.
51. Zheng J., Yin J., Huang R., et al. Meta-analysis reveals an association of STAT4 polymorphisms with systemic autoimmune disorders and anti-dsDNA antibody. Hum Immunol 2013, 74(8):986-992.
52. Perricone C., Ciccacci C., Ceccarelli F., et al. TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development. Immunogenetics 2013, 65(10):703-709.
53. Kaiser R., Li Y., Chang M., et al. Genetic risk factors for thrombosis in systemic lupus erythematosus. JRheumatol 2012, 39(8):1603-1610.
54. Morris D.L., Vyse T.J. Analysis of systemic lupus erythematosus sub-phenotype data for genetic association. Curr Opin Rheumatol 2012, 24(5):482-488.
55. Sanchez E., Nadig A., Richardson B.C., et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis 2011, 70(10):1752-1757.
56. Taylor K.E., Chung S.A., Graham R.R., et al. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet 2011, 7(2):e1001311.
57. Yang W., Zhao M., Hirankarn N., et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet 2009, 18(11):2063-2070.
58. Bucala R. MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity. JClin Immunol 2013, 33(Suppl 1):S72-S78.
59. Borchers A.T., Leibushor N., Naguwa S.M., et al. Lupus nephritis: a critical review. Autoimmun Rev 2012, 12(2):174-194.
60. Schwartzman-Morris J., Putterman C. Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol 2012, 2012:604892.
61. Maroz N., Segal M.S. Lupus nephritis and end-stage kidney disease. Am J Med Sci 2013, 346(4):319-323.
62. Nanda S.K., Venigalla R.K., Ordureau A., et al. Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. JExp Med 2011, 208(6):1215-1228.
63. Adrianto I., Wang S., Wiley G.B., et al. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum 2012, 64(11):3695-3705.
64. Genovese G., Friedman D.J., Ross M.D., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329(5993):841-845.
65. Freedman B.I., Kopp J.B., Langefeld C.D., et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. JAm Soc Nephrol 2010, 21(9):1422-1426.
66. Freedman B.I., Langefeld C.D., Andringa K.K., et al. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheum 2014, 66(2):390-396.
67. Tzur S., Rosset S., Shemer R., et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010, 128(3):345-350.
68. Kopp J.B., Nelson G.W., Sampath K., et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. JAm Soc Nephrol 2011, 22(11):2129-2137.
69. Parsa A., Kao W.H., Xie D., et al. APOL1 risk variants, race, and progression of chronic kidney disease. NEngl J Med 2013, 369(23):2183-2196.
70. Lipkowitz M.S., Freedman B.I., Langefeld C.D., et al. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int 2013, 83(1):114-120.
71. Lin C.P., Adrianto I., Lessard C.J., et al. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun 2012, 13(3):232-238.
72. Li X., Ptacek T.S., Brown E.E., et al. Fcgamma receptors: structure, function and role as genetic risk factors in SLE. Genes Immun 2009, 10(5):380-389.
73. Zidan H.E., Sabbah N.A., Hagrass H.A., et al. Association of FcgammaRIIB and FcgammaRIIA R131H gene polymorphisms with renal involvement in Egyptian systemic lupus erythematosus patients. Mol Biol Rep 2014, 41(2):733-739.
74. Alonso-Perez E., Suarez-Gestal M., Calaza M., et al. Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study. PLoS One 2012, 7(9):e45356.
75. Taylor K.E., Remmers E.F., Lee A.T., et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 2008, 4(5):e1000084.
76. Bolin K., Sandling J.K., Zickert A., et al. Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis. PLoS One 2013, 8(12):e84450.
77. Gateva V., Sandling J.K., Hom G., et al. Alarge-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41(11):1228-1233.
78. Zhou X.J., Cheng F.J., Qi Y.Y., et al. Areplication study from Chinese supports association between lupus-risk allele in TNFSF4 and renal disorder. Biomed Res Int 2013, 2013:597921.
79. Barnabe C., Joseph L., Belisle P., et al. Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care Res (Hoboken) 2012, 64(1):138-143.
80. Gonzalez L.A., Toloza S.M., McGwin G., et al. Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes. Lupus 2013, 22(12):1214-1224.
81. Krishnan E., Hubert H.B. Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis 2006, 65(11):1500-1505.
82. Lau C.S., Yin G., Mok M.Y. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 2006, 15(11):715-719.
83. Peschken C.A., Esdaile J.M. Systemic lupus erythematosus in North American Indians: a population based study. JRheumatol 2000, 27(8):1884-1891.
84. Alarcon-Riquelme M.E., Ziegler J.T., Comeau M.E., et al. GWAS in Hispanic and Latin American individuals enriched fro Amerindian ancestry identifies a new locus associated with systemic lupus erythematosus. Arthritis Rheum 2013, 65(S10):S695.
85. Sawcer S., Hellenthal G., Pirinen M., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476(7359):214-219.
86. Eyre S., Bowes J., Diogo D., et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 2012, 44(12):1336-1340.
87. Yu B., Guan M., Peng Y., et al. Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus. Arthritis Rheum 2011, 63(11):3487-3492.
88. Rahman P., Gladman D.D., Urowitz M.B., et al. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001, 10(2):93-96.
89. Alarcon G.S., McGwin G., Bastian H.M., et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001, 45(2):191-202.
90. Becker-Merok A., Nossent H.C. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. JRheumatol 2006, 33(8):1570-1577.
91. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40(9):1725.
92. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25(11):1271-1277.
93. Bentham J., Vyse T.J. The development of genome-wide association studies and theirapplication to complex diseases, including lupus. Lupus 2013, 22(12):1205-1213.
94. Wang C., Ahlford A., Laxman N., et al. Contribution of IKBKE and IFIH1 gene variants to SLE susceptibility. Genes Immun 2013, 14(4):217-222.
95. Zhong H., Li X.L., Li M., et al. Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res Ther 2011, 13(6):R186.
96. He C.F., Liu Y.S., Cheng Y.L., et al. TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus 2010, 19(10):1181-1186.
97. Okada Y., Shimane K., Kochi Y., et al. Agenome-wide association study identified AFF1 as a susceptibility locus for systemic lupus eyrthematosus in Japanese. PLoS Genet 2012, 8(1):e1002455.
98. Adrianto I., Wen F., Templeton A., et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet 2011, 43(3):253-258.
99. Lodolce J.P., Kolodziej L.E., Rhee L., et al. African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. JImmunol 2010, 184(12):7001-7009.
100. Diaz-Gallo L.M., Sanchez E., Ortego-Centeno N., et al. Evidence of new risk genetic factor to systemic lupus erythematosus: the UBASH3A gene. PLoS One 2013, 8(4):e60646.
101. Budarf M.L., Goyette P., Boucher G., et al. Atargeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun 2011, 12(1):51-58.
102. Ramos P.S., Criswell L.A., Moser K.L., et al. Acomprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 2011, 7(12):e1002406.
103. Sanchez E., Comeau M.E., Freedman B.I., et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum 2011, 63(11):3493-3501.
104. Sawalha A.H., Webb R., Han S., et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One 2008, 3(3):e1727.
105. Webb R., Wren J.D., Jeffries M., et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum 2009, 60(4):1076-1084.
106. Bowness P., Davies K.A., Norsworthy P.J., et al. Hereditary C1q deficiency and systemic lupus erythematosus. QJM 1994, 87(8):455-464.
107. Nishino H., Shibuya K., Nishida Y., et al. Lupus erythematosus-like syndrome with selective complete deficiency of C1q. Ann Intern Med 1981, 95(3):322-324.
108. Suzuki Y., Ogura Y., Otsubo O., et al. Selective deficiency of C1s associated with a systemic lupus erythematosus-like syndrome. Report of a case. Arthritis Rheum 1992, 35(5):576-579.
109. Walport M.J., Davies K.A., Morley B.J., et al. Complement deficiency and autoimmunity. Ann N Y Acad Sci 1997, 815:267-281.
110. Cao C.W., Li P., Luan H.X., et al. Association study of C1qA polymorphisms with systemic lupus erythematosus in a Han population. Lupus 2012, 21(5):502-507.
111. Yu B., Chen Y., Wu Q., et al. The association between single-nucleotide polymorphisms of NCF2 and systemic lupus erythematosus in Chinese mainland population. Clin Rheumatol 2011, 30(4):521-527.
112. Hughes T., Kim-Howard X., Kelly J.A., et al. Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. Arthritis Rheum 2011, 63(6):1689-1697.
113. Suarez-Gestal M., Calaza M., Endreffy E., et al. Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 2009, 11(3):R69.
114. Yang W., Shen N., Ye D.Q., et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 2010, 6(2):e1000841.
115. Molineros J.E., Kim-Howard X., Deshmukh H., et al. Admixture in Hispanic Americans: its impact on ITGAM association and implications for admixture mapping in SLE. Genes Immun 2009, 10(5):539-545.
116. Yasutomo K., Horiuchi T., Kagami S., et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001, 28(4):313-314.
117. Belguith-Maalej S., Hadj-Kacem H., Kaddour N., et al. DNase1 exon2 analysis in Tunisian patients with rheumatoid arthritis, systemic lupus erythematosus and Sjogren syndrome and healthy subjects. Rheumatol Int 2009, 30(1):69-74.
118. Briggs T.A., Rice G.I., Daly S., et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 2011, 43(2):127-131.
119. Luo X., Yang W., Ye D.Q., et al. Afunctional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 2011, 7(6):e1002128.
120. Lofgren S.E., Frostegard J., Truedsson L., et al. Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun 2012, 13(3):268-274.
121. Abelson A.K., Delgado-Vega A.M., Kozyrev S.V., et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis 2009, 68(11):1746-1753.
122. Yuan H., Feng J.B., Pan H.F., et al. Ameta-analysis of the association of STAT4 polymorphism with systemic lupus erythematosus. Mod Rheumatol 2010, 20(3):257-262.
123. Namjou B., Sestak A.L., Armstrong D.L., et al. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum 2009, 60(4):1085-1095.
124. Sigurdsson S., Goring H.H., Kristjansdottir G., et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 2008, 17(6):872-881.
125. Sigurdsson S., Padyukov L., Kurreeman F.A., et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 2007, 56(7):2202-2210.
126. Sigurdsson S., Nordmark G., Goring H.H., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005, 76(3):528-537.
127. Lessard C.J., Adrianto I., Ice J.A., et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet 2012, 90(4):648-660.
128. Shen N., Fu Q., Deng Y., et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci USA 2010, 107(36):15838-15843.
129. Lee Y.H., Lee H.S., Choi S.J., et al. Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clin Exp Rheumatol 2012, 30(2):262-265.
130. Kamatani Y., Matsuda K., Ohishi T., et al. Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population. JHum Genet 2008, 53(1):64-73.
131. Jacob C.O., Eisenstein M., Dinauer M.C., et al. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci USA 2012, 109(2):E59-E67.
132. Yu H.H., Liu P.H., Lin Y.C., et al. Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients. Lupus 2010, 19(10):1219-1228.
133. Kozyrev S.V., Abelson A.K., Wojcik J., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008, 40(2):211-216.
134. Fan Y., Tao J.H., Zhang L.P., et al. The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis. Int J Immunogenet 2011, 38(2):151-159.
135. Delgado-Vega A.M., Dozmorov M.G., Quiros M.B., et al. Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein. Ann Rheum Dis 2012, 71(7):1219-1226.
136. Chen Y., Wu Q., Shao Y., et al. Identify the association between polymorphisms of BLK and systemic lupus erythematosus through unlabelled probe-based high-resolution melting analysis. Int J Immunogenet 2012, 39(4):321-327.
137. Lu R., Vidal G.S., Kelly J.A., et al. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun 2009, 10(5):397-403.
138. Yang J., Yang W., Hirankarn N., et al. ELF1 is associated with systemic lupus erythematosus in Asian populations. Hum Mol Genet 2011, 20(3):601-607.
139. Sheng Y.J., Gao J.P., Li J., et al. Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. Rheumatology (Oxford) 2011, 50(4):682-688.
140. Vazgiourakis V.M., Zervou M.I., Choulaki C., et al. Acommon SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis. Ann Rheum Dis 2011, 70(12):2184-2190.
141. Kyogoku C., Langefeld C.D., Ortmann W.A., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004, 75(3):504-507.
142. Manjarrez-Orduno N., Marasco E., Chung S.A., et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet 2012, 44(11):1227-1230.
143. Furukawa H., Kawasaki A., Oka S., et al. Association of a single nucleotide polymorphism in the SH2D1A intronic region with systemic lupus erythematosus. Lupus 2013, 22(5):497-503.
144. Edberg J.C., Wu J., Langefeld C.D., et al. Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 2008, 17(8):1147-1155.
145. Barcellos L.F., May S.L., Ramsay P.P., et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 2009, 5(10):e1000696.
146. Morris D.L., Taylor K.E., Fernando M.M., et al. Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. Am J Hum Genet 2012, 91(5):778-793.
147. Namjou B., Kothari P.H., Kelly J.A., et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 2011, 12(4):270-279.
148. Lee-Kirsch M.A., Gong M., Chowdhury D., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007, 39(9):1065-1067.
149. Zhao H., Yang W., Qiu R., et al. An intronic variant associated with systemic lupus erythematosus changes the binding affinity of Yinyang1 to downregulate WDFY4. Genes Immun 2012, 13(7):536-542.
150. Kaiser R., Taylor K.E., Deng Y., et al. Brief report: single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians. Arthritis Rheum 2013, 65(1):211-215.